carbenoxolone sodium has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nehru, B; Thakur, P | 1 |
| Brotchie, JM; Calos, M; Campbell, JC; O'Connor, KA; Phookan, S; Pilitsis, JG; Shin, DS; Smith, A; Sutton, AC; Walling, I; Yu, W | 1 |
2 other study(ies) available for carbenoxolone sodium and Parkinsonian Disorders
| Article | Year |
|---|---|
Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson's disease in a rotenone-based model.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Apoptosis; Carbenoxolone; DNA-Binding Proteins; Dopamine; Heat Shock Transcription Factors; Heat-Shock Proteins; Male; Mesencephalon; Motor Activity; Oxidative Stress; Parkinsonian Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Rotenone; Transcription Factors; Tyrosine 3-Monooxygenase; Ubiquitin | 2014 |
Gap junction blockers attenuate beta oscillations and improve forelimb function in hemiparkinsonian rats.
Topics: Animals; Beta Rhythm; Carbenoxolone; Forelimb; Gap Junctions; Globus Pallidus; Injections, Intraventricular; Male; Octanols; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Recovery of Function | 2015 |